Results 21 to 30 of about 12,565 (224)

Fatal outcome in classic Kaposi's sarcoma [PDF]

open access: yes, 2010
First described in 1872, Kaposi's sarcoma is defined as a rare multifocal tumor that originates in the endothelial cells and presents with cutaneous and extracutaneous manifestations. The classic form is most common in elderly men and progression is slow.
Almeida, Fernando Augusto de   +4 more
core   +3 more sources

Non-detection of human herpesvirus 8 (HHV-8) DNA in HHV-8-seropositive blood donors from three Brazilian regions. [PDF]

open access: yesPLoS ONE, 2011
Human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma-associated herpesvirus (KSHV), is the etiologic agent of all forms of Kaposi's sarcoma, primary effusion lymphoma and the plasmablastic cell variant of multicentric Castleman disease. In endemic
José Eduardo Levi   +6 more
doaj   +1 more source

Unusual immunophenotypic variant of large B-cell lymphoma associated with HHV-8 and EBV in an HIV positive patient

open access: yesHuman Pathology: Case Reports, 2015
Human herpesvirus type 8, also known as Kaposi's sarcoma-associated herpesvirus (HHV-8/KSHV) has been associated with several lymphoproliferative disorders including Kaposi's sarcoma, primary effusion lymphoma (PEL), cases of multicentric Castleman's ...
Roberto Ruiz-Cordero, MD   +8 more
doaj   +1 more source

Role of the ubiquitin system and tumor viruses in AIDS-related cancer [PDF]

open access: yes, 2007
Tumor viruses are linked to approximately 20% of human malignancies worldwide. This review focuses on examples of human oncogenic viruses that manipulate the ubiquitin system in a subset of viral malignancies; those associated with AIDS.
Julia Shackelford, Joseph S Pagano
core   +2 more sources

Kaposi's sarcoma-associated herpesvirus infection and Kaposi's sarcoma in Brazil

open access: yesBrazilian Journal of Medical and Biological Research, 2006
Kaposi's sarcoma (KS) became a critical health issue with the emergence of acquired immunodeficiency syndrome (AIDS) in the 1980s. Four clinical-epidemiological forms of KS have been described: classical KS, endemic KS, iatrogenic KS, and AIDS-associated
S. Ramos-da-Silva   +3 more
doaj   +1 more source

Raman tweezers provide the fingerprint of cells supporting the late stages of KSHV reactivation [PDF]

open access: yes, 2009
Kaposi's sarcoma-associated herpesvirus (KSHV) has both latent and lytic phases of replication. The molecular switch that triggers a reactivation is still unclear. Cells from S phase of cell cycle provide apt conditions for an active reactivation.
Akula   +56 more
core   +1 more source

Kaposi’s sarcoma with the eyelid involvement (6 clinical cases)

open access: yesAlʹmanah Kliničeskoj Mediciny, 2018
Kaposi's sarcoma is a multifocal tumor from vascular endothelium with a low grade of malignancy. It develops due to underlying immune deficiency and is associated with human herpesvirus 8. Kaposi's sarcoma of the eyelids is rare, and its diagnosis can be
E. E. Grishina
doaj   +1 more source

Modulation of Autophagy-Like Processes by Tumor Viruses [PDF]

open access: yes, 2014
Autophagy is an intracellular degradation pathway for long-lived proteins and organelles. This process is activated above basal levels upon cell intrinsic or environmental stress and dysregulation of autophagy has been linked to various human diseases ...
Mack, Hildegard I. D., Munger, Karl
core   +1 more source

Recent advances in understanding Kaposi’s sarcoma-associated herpesvirus [version 1; referees: 2 approved]

open access: yesF1000Research, 2016
Kaposi’s sarcoma (KS)-associated herpesvirus (KSHV) is an oncogenic human herpesvirus. KSHV is associated with three cancers in the human population: KS, primary effusion lymphoma (PEL), and multicentric Castleman’s disease (MCD). KS is the leading cause
Nathan J. Dissinger, Blossom Damania
doaj   +1 more source

Targeting the ATP-dependent formation of herpesvirus ribonucleoprotein particle assembly as an antiviral approach [PDF]

open access: yes, 2016
Human herpesviruses are responsible for a range of debilitating acute and recurrent diseases, including a number of malignancies. Current treatments are limited to targeting the herpesvirus DNA polymerases, however with emerging viral resistance and ...
Foster, R   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy